BioAge Labs (BIOA) Abandons Obesity Drug Amid Shareholder Lawsuit - Hagens Berman

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/27/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. AWK
8. DRI
9. ULS
10. PRME

Go back to BioAge Labs (BIOA) Abandons Obesity Drug Amid Shareholder Lawsuit - Hagens Berman
BIOAMBER, Inc. (NASDAQ: BIOA) Delayed: 7.05 -0.16 (2.22%)
Previous Close $7.21    52 Week High $8.73 
Open $7.26    52 Week Low $2.86 
Day High $7.30    P/E N/A 
Day Low $7.03    EPS $-3.82 
Volume 630,289